当前位置:首页 - 行情中心 - 华东医药(000963) - 财务分析 - 现金流量表

华东医药

(000963)

  

流通市值:478.40亿  总市值:478.59亿
流通股本:17.53亿   总股本:17.54亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金23,464,347,633.1510,376,323,259.3847,603,508,452.3535,143,641,924.19
  收到的税费返还2,589,794.812,570,13116,771,253.5915,291,551.75
  收到其他与经营活动有关的现金400,570,732.1124,934,981.83853,630,530.93691,105,479.99
  经营活动现金流入小计23,867,508,160.0610,503,828,372.2148,473,910,236.8735,850,038,955.93
  购买商品、接受劳务支付的现金14,522,926,495.717,960,726,465.3629,990,020,022.0622,966,598,545.25
  支付给职工以及为职工支付的现金2,724,872,670.381,542,554,152.985,380,354,732.474,049,472,030.97
  支付的各项税费1,573,252,891.88709,327,509.542,934,697,014.282,277,592,721.51
  支付其他与经营活动有关的现金2,547,036,571.461,143,556,006.965,923,234,096.893,945,523,714.02
  经营活动现金流出小计21,368,088,629.4311,356,164,134.8444,228,305,865.733,239,187,011.75
  经营活动产生的现金流量净额2,499,419,530.63-852,335,762.634,245,604,371.172,610,851,944.18
二、投资活动产生的现金流量:
  收回投资收到的现金1,979,259.7-14,700,00014,700,000
  取得投资收益收到的现金16,907,623.61-70,463,762.9649,321,490.47
  处置固定资产、无形资产和其他长期资产收回的现金净额4,772,727.5174,063.5121,100,980.3510,619,487.83
  收到的其他与投资活动有关的现金81,650,074.99---
  投资活动现金流入小计105,309,685.8174,063.51106,264,743.3174,640,978.3
  购建固定资产、无形资产和其他长期资产支付的现金718,496,969.99261,855,876.921,574,454,008.411,085,447,151.48
  投资支付的现金149,419,257.47129,618,537.85127,677,933.8666,060,775
  支付其他与投资活动有关的现金--73,905,213.881,524,947.75
  投资活动现金流出小计867,916,227.46391,474,414.771,776,037,156.151,153,032,874.23
  投资活动产生的现金流量净额-762,606,541.65-391,400,351.26-1,669,772,412.84-1,078,391,895.93
三、筹资活动产生的现金流量:
  取得借款收到的现金1,683,103,844.51,131,688,831.323,251,416,517.562,519,372,648
  收到其他与筹资活动有关的现金55,903,162.77800,000988,854,695.83220,601,111.1
  筹资活动现金流入小计1,739,007,007.271,132,488,831.324,240,271,213.392,739,973,759.1
  偿还债务支付的现金1,613,149,927.021,047,678,831.323,522,627,345.722,642,267,908.35
  分配股利、利润或偿付利息支付的现金1,042,083,356.7137,291,974.451,735,408,728.321,758,448,442.05
  其中:子公司支付给少数股东的股利、利润750,000-43,280,794.1711,873,140.39
  支付其他与筹资活动有关的现金67,730,676.8112,306,031.361,804,706,799.29701,895,348.32
  筹资活动现金流出小计2,722,963,960.541,097,276,837.137,062,742,873.335,102,611,698.72
  筹资活动产生的现金流量净额-983,956,953.2735,211,994.19-2,822,471,659.94-2,362,637,939.62
四、汇率变动对现金及现金等价物的影响-1,458,952.03-4,179,294.34-7,589,821.17-6,921,970.54
五、现金及现金等价物净增加额751,397,083.68-1,212,703,414.04-254,229,522.78-837,099,861.91
  加:期初现金及现金等价物余额4,735,921,663.94,735,921,663.94,990,151,186.684,990,151,186.68
  期末现金及现金等价物余额5,487,318,747.583,523,218,249.864,735,921,663.94,153,051,324.77
补充资料:
  净利润1,839,889,537.26-3,410,846,772.45-
  资产减值准备36,369,759.62-224,808,627.71-
  固定资产和投资性房地产折旧297,386,072.41-499,497,564.68-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧297,386,072.41-499,497,564.68-
  无形资产摊销242,553,401.28-440,941,860.17-
  长期待摊费用摊销5,692,786.17-10,071,176.02-
  处置固定资产、无形资产和其他长期资产的损失-1,424,072.58--2,263,396.06-
  固定资产报废损失4,849,064.34-3,321,403.16-
  财务费用33,109,723.52-76,945,685.71-
  投资损失-28,392,197.57-75,923,097.56-
  递延所得税-66,018,506.38--136,654,844.97-
  其中:递延所得税资产减少-54,387,017.62--163,235,635.39-
    递延所得税负债增加-11,631,488.76-26,580,790.42-
  存货的减少450,705,751.62--828,390,560.68-
  经营性应收项目的减少-362,902,564.73--673,323,235.76-
  经营性应付项目的增加7,945,713.35-1,053,848,353.38-
  其他0-521,113.34-
  现金的期末余额5,487,318,747.58-4,735,921,663.9-
  减:现金的期初余额4,735,921,663.9-4,990,151,186.68-
  加:现金等价物的期末余额0---
  减:现金等价物的期初余额0---
  现金及现金等价物的净增加额751,397,083.68--254,229,522.78-
公告日期2026-08-272026-04-242026-04-242025-10-28
审计意见(境内)标准无保留意见
TOP↑